A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel Consultations-Reference-Cited by-同舟云学术

A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel Consultations

Published:2024-04-13 Issue:7 Volume:42 Page:797-810
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Wang Junfeng,Pouwels Xavier,Ramaekers Bram,Frederix Geert,van Lieshout Chris,Hoogenveen Rudolf,Li Xinyu,de Wit G. Ardine,Joore Manuela,Koffijberg Hendrik,van Giessen Anoukh,Knies Saskia,Feenstra Talitha^ORCID,

Funder

Zorginstituut Nederland

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40273-024-01376-w.pdf

Reference48 articles.

1. Hoang VP, et al. A systematic review of modelling approaches in economic evaluations of health interventions for drug and alcohol problems. BMC Health Serv Res. 2016;16:1–14.

2. Tappenden P, et al. Whole disease modeling to inform resource allocation decisions in cancer: a methodological framework. Value in Health. 2012;15(8):1127–36.

3. Tappenden P, et al. Using whole disease modeling to inform resource allocation decisions: economic evaluation of a clinical guideline for colorectal cancer using a single model. Value in health. 2013;16(4):542–53.

4. de Boer PT, et al. Unremarked or unperformed? Systematic review on reporting of validation efforts of health economic decision models in seasonal influenza and early breast cancer. Pharmacoeconomics. 2016;34:833–45.

5. Afzali HHA, Karnon J. Addressing the challenge for well informed and consistent reimbursement decisions. Pharmacoeconomics. 2011;29(10):823.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective;PharmacoEconomics;2024-05-08